Rnai agent targeting SARM1 and the pharmaceutical use thereof
TW202627086APending Publication Date: 2026-07-01TUOJIE BIOTECH (SHANGHAI) CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114123097
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-03
- Filing Date
- 2025-06-19
- Publication Date
- 2026-07-01
Abstract
The present disclosure relates to RNAi agent targeting SARM1 and the pharmaceutical use thereof. Specifically, the present disclosure also relates to pharmaceutical composition, cells or kit comprising the RNAi agent, and method for treating and / or preventing subjects suffering from related disorders by using the RNAi agent.
Need to check novelty before this filing date? Find Prior Art